Stay Informed
Subscribe to receive safety alerts
By email | By RSS

What's New

Micro-bubble Contrast Agents (marketed as Definity (Perflutren Lipid Microsphere) Injectable Suspension and Optison (Perflutren Protein-Type A Microspheres for Injection) - Changes to the Boxed Warning, Warnings, and Contraindications sections of the prescribing information to reflect conclusions of FDA reviews of information received following the addition of new contraindications and warnings in October 2007.
(Posted 07/17/2008)

Electronic Medical Devices - Possible malfunction of Electronic Medical Devices caused by Computed Tomography (CT) Scanning on patients with implanted and external electronic medical devices.
(Posted 07/16/2008)

Sodium Polystyrene Sulfonate Suspension - Recall of 2 lots of the product due to the presence of yeast which could affect patients who are immunocompromised.
(Posted 07/16/2008)

Avastin (bevacizumab) and sunitinib malate - Reports of microangiopathic hemolytic anemia in patients treated with this unapproved combination.
(Posted 07/14/2008)

May 2008 Safety-Related Labeling Changes - Summary of safety-related revisions to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS sections of drug Prescribing Information, plus Patient Package Inserts and Medication Guides.
(Posted 07/10/2008)

Herceptin 440 mg Vials and BWFI Diluent - Complaints of damaged and broken vials of Herceptin 440 mg and BWFI diluent that may lead to a loss of sterility, which may cause infections in patients.
(Posted 07/10/2008)

Fluoroquinolone Antimicrobial Drugs - BOXED WARNING and Medication Guide to be added to prescribing information to strengthen existing warnings about the increased risk of developing tendinitis and tendon rupture in patients taking fluoroquinolones for systemic use.
(Posted 07/08/2008)

Rize 2 The Occasion Capsules and Rose 4 Her Capsules - Certain lots of both products were recalled because they contained an undeclared ingredient.
(Posted 07/02/2008)

Recombinant Human Bone Morphogenetic Protein in Cervical Spine Fusion - Reports of life-threatening complications associated with recombinant human Bone Morphogenetic Protein when used in the cervical spine.
(Posted 07/02/2008)

Myfortic (mycophenolate acid) - Dear Healthcare Professional Letter sent by manufacturer regarding reports of Progressive Multifocal Leukoencephalopathy in patients treated with Myfortic.
(Posted 06/26/2008)

July 2008 Patient Safety News - Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients.
(Posted 07/01/2008)

April 2008 Safety-Related Labeling Changes - Summary of safety-related revisions to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS sections of drug Prescribing Information, plus Patient Package Inserts and Medication Guides.
(Posted 07/01/2008)

March 2008 Safety-Related Labeling Changes - Summary of safety-related revisions to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS sections of drug Prescribing Information, plus Patient Package Inserts and Medication Guides.
(Posted 07/01/2008)

2% Chlorhexidine Gluconate Cloth Patient Preoperative Skin Preparation Product - Product recalled due to the presence of Burkholderia cepacia.
(Posted 06/30/2008)

Safety Information

Medical Product
Reporting

FDA MedWatch and Patient Safety
Video tutorial with optional quiz for healthcare professional students, healthcare providers, and their patients.